1. A common atopy‐associated variant in the Th2 cytokine locus control region impacts transcriptional regulation and alters SMAD3 and SP1 binding. Issue 5 (25th March 2014) Authors: Kretschmer, A.; Möller, G.; Lee, H.; Laumen, H.; von, C.; Schramm, K.; Prokisch, H.; Eyerich, S.; Wahl, S.; Baurecht, H.; Franke, A.; Claussnitzer, M.; Eyerich, K.; Teumer, A.; Milani, L.; Klopp, N.; Hauck, S. M.; Illig, T.; Peters, A.; Waldenberger, M. Journal: Allergy Issue: Volume 69:Issue 5(2014:May) Page Start: 632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addiction: an underestimated problem in psoriasis health care. (31st March 2017) Authors: Zink, A.; Herrmann, M.; Fischer, T.; Lauffer, F.; Garzorz‐Stark, N.; Böhner, A.; Spinner, C.D.; Biedermann, T.; Eyerich, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 8(2017) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addictions in patients with atopic dermatitis: a cross‐sectional pilot study in Germany. (8th October 2021) Authors: Pilz, A.C.; Durner, V.; Schielein, M.C.; Schuster, B.; Beckmann, J.; Biedermann, T.; Eyerich, K.; Zink, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 1(2022) Page Start: 84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessing genotypes to predict therapeutic outcome in psoriasis. (12th January 2020) Authors: Eyerich, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 1(2020) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study. (30th July 2020) Authors: Augustin, M.; Kleyn, C.E.; Conrad, C.; Sator, P.G.; Ståhle, M.; Eyerich, K.; Radtke, M.A.; Bundy, C.; Mellars, L.; Greggio, C.; Cordey, M.; Koscielny, V.; Griffiths, C.E.M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 1(2021) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion. (6th May 2019) Authors: Thyssen, J.P.; de Bruin‐Weller, M.S.; Paller, A.S.; Leshem, Y.A.; Vestergaard, C.; Deleuran, M.; Drucker, A.M.; Foelster‐Holst, R.; Traidl‐Hoffmann, C.; Eyerich, K.; Taieb, A.; Su, J.C.; Bieber, T.; Cork, M.J.; Eichenfield, L.F.; Guttman‐Yassky, E.; Wollenberg, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 7(2019) Page Start: 1224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Continued treatment with secukinumab is associated with high retention or regain of response. (17th July 2019) Authors: Augustin, M.; Thaci, D.; Eyerich, K.; Pinter, A.; Radtke, M.; Lauffer, F.; Mrowietz, U.; Gerdes, S.; Pariser, D.; Lebwohl, M.; Sieder, C.; Melzer, N.; Reich, K. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Continued treatment with secukinumab is associated with high retention or regain of response. (1st January 2020) Authors: Augustin, M.; Thaci, D.; Eyerich, K.; Pinter, A.; Radtke, M.; Lauffer, F.; Mrowietz, U.; Gerdes, S.; Pariser, D.; Lebwohl, M.; Sieder, C.; Melzer, N.; Reich, K. Journal: British journal of dermatology Issue: Volume 182:Number 1(2020) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Corrigendum: Is the humoral immunity dispensable for the pathogenesis of psoriasis?. (28th November 2019) Authors: Thomas, J.; Küpper, M.; Batra, R.; Jargosch, M.; Atenhan, A.; Baghin, V.; Krause, L.; Lauffer, F.; Biedermann, T.; Theis, F.J.; Eyerich, K.; Schmidt‐Weber, C.B.; Eyerich, S.; Garzorz‐Stark, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 12(2019) Page Start: 2380 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019. (14th December 2020) Authors: Luger, T.; Dirschka, T.; Eyerich, K.; Gollnick, H.; Gupta, G.; Lambert, J.; Micali, G.; Ochsendorf, F.; Ständer, S.; Traidl‐Hoffmann, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34(2020)supplement 7 Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗